Funding for this research was provided by:
Irish Cancer Society (CCRC13GAL)
National Cancer Institute (P50 CA098258, P30 CA016672)
North East Cancer Research and Education Trust
Health Research Board/Science Foundation Ireland (TRA 2010/08)
Received: 19 July 2016
Accepted: 23 January 2018
First Online: 9 February 2018
Ethics approval and consent to participate
: All endometrial cancer cell lines used in this study are commercially available with the exception of E1078D cell line which was kindly provided by Prof Eric Asselin (University of Quebec). The informed consent for EN1078D cell line was attained and research studies approved by the Montreal University Institutional Review Board.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.